BOOKMARK
  • Korean|
  • Chinese|
  • Japanese|
  • Vietnamese
본문내용 바로가기

Aju Business Daily

SEARCH
  • ECONOMY
  • ENTERTAINMENT
  • IT
  • South Korea
  • North Korea
  • WORLD
  • SPORTS
  • LIFESTYLE
  • AUTO MOTIVE
  • OPINION
  • PEOPLE
  • MILITARY
Home > Health > article

Remdesvir to be introduced for treatment of COVID-19 in S. Korea

Lim Chang-won Reporter(cwlim34@ajunews.com) | Posted : May 29, 2020, 13:42 | Updated : May 29, 2020, 14:50
  • 트위터
  • 페이스북
  • 웨이보

[REUTERS / YONHAP]

SEOUL -- Remdesivir, an antiviral medication developed by Gilead Sciences to treat Ebola virus disease, will be introduced in South Korea as a specific treatment for COVID-19 following the positive assessment of clinical trials by experts involved in South Korea's national epidemic control center.

Remdesivir has been authorized for emergency use in the United States and some other countries. It may shorten the time it takes to recover from infection. The Korea Centers for Disease Control and Prevention (KCDC) has said that remdesivir can be used for severe patients.

"There are clinical trials on remdesivir the U.S. and in South Korea. The clinical results are positive, so we are preparing to introduce them," Food and Drug Safety Minister Lee Eui-kyung told a regular press briefing on Friday. Her comment followed a meeting of experts who have discussed remdesivir's effectiveness in treating COVID-19 patients.

Dozens of antiviral drugs have been tested, with researchers involved in experiments to check the efficacy of various anti-viral drugs, including remdesivir.

KCDC director Jeong Eun-kyeong said remdesvir would be purchased and imported through a simplified and quick import procedure. She promised to work out quidelines on the use of remdesvir and its sideeffects.

  • Lim Chang-won Reporter
  • email : cwlim34@ajunews.com
© Aju Business Daily & www.ajunews.com Copyright: All materials on this site may not be reproduced, distributed, transmitted, displayed, published or broadcast without the authorization from the Aju News Corporation.
  • twitter
  • facebook
  • weibo
  • link copy
  • LIST
  • TOP

Related news

  • .Hyundai department store chain ready to open nature-friendly future department store.
    Hyundai department store chain ready to open nature-friendly…
  • .Syringes for COVID-19 vaccines added to list of K-quarantine technologies.
    Syringes for COVID-19 vaccines added to list of 'K-quarantin…
  • .KCC unveils diversified lineup of bio-paint capable of curbing virus spread.
    KCC unveils diversified lineup of bio-paint capable of curbi…

Real Time Photo News

  • .BTS agency posts record earnings in 2020 on brisk online activities and album sales .

    BTS agency posts record earnings in 2020 on brisk online activities and album sales

  • .[FOCUS] BTS agency leagues with Universal Music to launch new K-pop band in US music scene.

    [FOCUS] BTS agency leagues with Universal Music to launch new K-pop band in US music scene

  • .CJ ENM aims to become major visual content producer thru partnership with Epic Games .

    CJ ENM aims to become major visual content producer thru partnership with Epic Games

  • .​Solo singer Sunmi to come back with new album Tail.

    ​Solo singer Sunmi to come back with new album 'Tail'

  • .Big Hits live-streaming joint venture gains reinforcements from Universal Music, YG.

    Big Hit's live-streaming joint venture gains reinforcements from Universal Music, YG

Latest News

more+

  • Prime Minister Chung stresses importance of 'borderless communication channel' to minimize informati…
  • State hospital succeeds in inserting wireless pacemakers into hearts of bradyarrhythmia patients
  • LG Electronics' joint venture with Canada's Magna awaits approval by shareholders in March
  • Sajo Seafood to launch raw tuna menu delivery service
  • Researchers find new roundworm species near Dokdo
Aju Business Daily
  • ABOUT US
  • CONTACT US
  • PRIVACY STATEMENT
  • Copyright Policy

Address : Aju News Corporation LEEMA Building, 11th floor, 42, Jong-ro 1-gil, Jongno-gu, Seoul.    Mail : swatchsjp@ajunews.com

Copyright ⓒ 2016 By Ajunews Corporation, All Rights Reserved.

Mobile view